Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 With Integrin Β1 Blocking Antibody OS2966
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0953
Full Text
Open PDFAbstract
Available in full text
Date
March 29, 2019
Authors
Publisher
American Association for Cancer Research (AACR)